Work

Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.19.3342

Authors: Bernard Escudier, Cezary Szczylik, Thomas E. Hutson, Tomasz Demkow, Michael Staehler, Frédéric Rolland, Sylvie Negrier, Nicole Laferriere, Urban J. Scheuring, David Cella, Sonalee Shah, Ronald M. Bukowski

Institutions: Cleveland Clinic, Institut Gustave Roussy, Centre Léon Bérard, Bayer (Germany)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2147186814

FWCI: 33.83

Cites: 30

Cited by: 501

Related to: 10